A newly approved option for pediatric patients with functional constipation significantly increased the frequency of bowel movements and improved other burdensome symptoms as well, according to a ...
BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the companies have reached an agreement with Sandoz Inc. (Sandoz) resolving ...
Please provide your email address to receive an email when new articles are posted on . Patients with constipation-predominant irritable bowel syndrome treated with a ...
Linaclotide is marketed by Allergan for the treatment of adults with moderate to severe IBS-C in Europe under the brand name CONSTELLA ®, and Ironwood’s partner Astellas received approval of ...
August 11, 2011 — The investigative drug linaclotide has been shown in 2 phase 3 placebo-controlled trials to safely and effectively reduce bowel and abdominal symptoms associated with chronic ...
A study, published in The American Journal of Gastroenterology, examined the efficacy and safety of linaclotide for patients with chronic idiopathic constipation. Philip Schoenfeld, MD, of ...
-- Agreement Also Returns to Allergan Rights to LINZESS® (linaclotide) in Mexico -- DUBLIN and CAMBRIDGE, Mass., Oct. 27, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical ...
“As many as 34 million people in the U.S. i suffer from chronic constipation and many patients are not fully satisfied with currently available treatments. ii I am encouraged by the results from these ...
— Top-line Results Show Trial Met All Primary and Secondary Endpoints — CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE ...
Linaclotide Receives Positive CHMP Opinion for the Treatment of IBS-C -Linaclotide is a first-in-class therapeutic option for the symptomatic treatment of moderate to severe irritable bowel syndrome ...
August 30, 2012 — The US Food and Drug Administration (FDA) approved the drug linaclotide (Linzess, Ironwood Pharmaceuticals) today for the treatment of chronic idiopathic constipation and irritable ...
Review the side-effects of Linaclotide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results